TNFRSF8 anticorps (PE)
-
- Antigène Voir toutes TNFRSF8 Anticorps
- TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp TNFRSF8 est conjugé à/à la PE
-
Application
- Flow Cytometry (FACS)
- Specificité
- The mouse monoclonal antibody Ber-H8 recognizes extracellular part of CD30 (Ki-1 antigen), a 105 kDa single chain glycoprotein expressed on Hodgkin's and Reed-Sternberg cells, it is also found in Burkitt's lymphomas, virus-infected T and B lymphocytes, and on normal B and T lymphocytes after activation (T lymphocytes that produce Th2-type cytokines and on CD4+/CD8+ T lymphocytes that co-express CD45RO and the IL4 receptor).
- Réactivité croisée (Details)
- Human
- Purification
- Purified antibody is conjugated with R-phycoerythrin (PE) under optimum conditions. Unconjugated antibody and free fluorochrome are removed by size-exclusion chromatography.
- Clone
- Ber-H8
- Isotype
- IgG1 kappa
- Top Product
- Discover our top product TNFRSF8 Anticorps primaire
-
-
- Indications d'application
- Flow cytometry: The reagent is designed for analysis of human blood cells using 10 μL reagent / 100 μL of whole blood or 106 cells in a suspension. The content of a vial (1 ml) is sufficient for 100 tests.
- Commentaires
-
The purified antibody is conjugated with R-Phycoerythrin (PE) under optimum conditions. The conjugate is purified by size-exclusion chromatography and adjusted for direct use. No reconstitution is necessary.
- Restrictions
- For Research Use only
-
- Buffer
- Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C
- Stockage commentaire
- Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.
-
-
Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60)." dans: PLoS ONE, Vol. 6, Issue 9, pp. e24119, (2011) (PubMed).
: "Increased expression and activation of CD30 induce apoptosis in human blood eosinophils." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 173, Issue 3, pp. 2174-83, (2004) (PubMed).
: "Extremely rapid and intense induction of apoptosis in human eosinophils by anti-CD30 antibody treatment in vitro." dans: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 4, pp. 2186-93, (2004) (PubMed).
: "Characterization of the CD30L binding domain on the human CD30 molecule using anti-CD30 antibodies." dans: Hybridoma, Vol. 19, Issue 1, pp. 43-8, (2000) (PubMed).
: "CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy." dans: Blood, Vol. 85, Issue 1, pp. 1-14, (1995) (PubMed).
: "
-
Cord blood CD4+ T cells respond to self heat shock protein 60 (HSP60)." dans: PLoS ONE, Vol. 6, Issue 9, pp. e24119, (2011) (PubMed).
-
- Antigène
- TNFRSF8 (Tumor Necrosis Factor Receptor Superfamily, Member 8 (TNFRSF8))
- Autre désignation
- CD30 (TNFRSF8 Produits)
- Synonymes
- anticorps CD30, anticorps D1S166E, anticorps Ki-1, anticorps Cd30, anticorps Ki, anticorps TNFRSF8, anticorps TNF receptor superfamily member 8, anticorps tumor necrosis factor receptor superfamily, member 8, anticorps TNFRSF8, anticorps Tnfrsf8
- Sujet
- TNF receptor superfamily member 8,CD30 is a type I transmembrane glycoprotein of the TNF receptor superfamily. CD30 was originally identified as a cell surface antigen of Hodgkins and Reed-Sternberg cells using monoclonal antibody Ki-1. The ligand for CD30 is CD30L (CD153). The binding of CD30 to CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation, and apoptotic cell death. CD30 has a critical role in the pathophysiology of Hodgkin's disease and other CD30+ lymphomas. CD30 acts as a costimulatory molecule in thymic negative selection. In addition to its expression on Hodgkin's and Reed-Sternberg cells, CD30 is also found in some non-Hodgkin's lymphomas (including Burkitt's lymphomas), virus-infected T and B cells, and on normal T and B cells after activation. In T cells, CD30 expression is present on a subset of T cells that produce Th2-type cytokines and on CD4+/CD8+ thymocytes that co-express CD45RO and the IL4 receptor. Soluble form of CD30 (sCD30) serves as a marker reflecting Th2 immune response.,Ki-1, TNFRSF8, CD30L receptor, D1S166E
- ID gène
- 943
- UniProt
- P28908
-